Category: Drug Discovery
Drug Discovery market research reports by Roots Analysis
-
GLP-1 Market: Industry Trends and Global Forecasts, till 2035
GLP-1 Market: Industry Trends and Global Forecasts, till 2035 GLP-1 Market: Industry Trends and Global Forecasts, till 2035 Distribution by Type of Molecule (Biologics and Small Molecules), Active Compound Used (Dulaglutide, Liraglutide, Orforglipron, Retatrutide, Semaglutide, Survodutide, Tirzepati ... Read More
-
Blockchain in Drug Discovery and Clinical Trials Market, 2023-2035
Blockchain in Drug Discovery and Clinical Trials Market, 2023-2035 Blockchain technology, also referred to as distributed ledger technology (DLT), serves an integral part of the pharmaceutical supply chain. It enhances the trackability and traceability of drugs and other pharmaceutical products, the ... Read More
-
HPAPI and Cytotoxic Drug Manufacturing Market (4th Edition), 2022-2035
HPAPI and Cytotoxic Drug Manufacturing Market (4th Edition), 2022-2035 Aided by the ongoing advancements in clinical pharmacology and oncology research, as well as the rising demand for targeted therapies, high potency active pharmaceutical ingredients (HPAPIs) and cytotoxic drugs have emerged as on ... Read More
-
Exosome Therapeutics Market, 2022-2035
Exosome Therapeutics Market, 2022-2035 In recent years, therapies utilizing extracellular vesicles have garnered significant attention among the industry stakeholders for the treatment of diverse target indication, primarily owing to the various benefits offered by them, including target specificit ... Read More
-
Digital Health Market: Focus on Digital Therapeutics (3rd Edition), 2023-2035
Digital Health Market: Focus on Digital Therapeutics (3rd Edition), 2023-2035 Digital Therapeutics, popularly known as DTx, represent a digital health solution which delivers medical interventions directly to the patients in order to treat, manage and prevent a disease. Such solutions usually emplo ... Read More
-
Synthetic Biology: Protein Design and Engineering Market- Focus on Services and Technology Providers – Market Distribution by Type of Protein Engineering Approach Used (Rational Designing, Directed Evolution and Semi-Rational Designing), Type of Protein (Antibodies, Peptides, Enzymes, Vaccines and Others), Type of Application (Therapeutics and Diagnostics), Type of End User (Pharma / Biotech Firms, CROs and Research / Academic Institutes) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa and Rest of the World)): Industry Trends and Global Forecasts, 2021-2035
Synthetic Biology: Protein Design and Engineering Market- Focus on Services and Technology Providers – Market Distribution by Type of Protein Engineering Approach Used (Rational Designing, Directed Evolution and Semi-Rational Designing), Type of Protein (Antibodies, Peptides, Enzymes, Vaccines and O ... Read More
-
RNA Therapeutics and RNA Vaccines Market, 2023-2035 (Forecasted Estimates)
RNA Therapeutics and RNA Vaccines Market, 2023-2035 (Forecasted Estimates) RNA THERAPEUTICS AND RNA VACCINES MARKET OVERVIEW The global RNA Vaccines and RNA Therapeutics market is estimated to be worth over USD 1.1 billion in 2035 and is expected to grow at compounded annual growth rate (CAGR) of 50 ... Read More
-
mRNA Therapeutics and Vaccines Market (2nd Edition), 2022-2035
mRNA Therapeutics and Vaccines Market (2nd Edition), 2022-2035 Messenger ribonucleic acid (mRNA) is a type of single-stranded ribonucleic acid (RNA), which helps in transferring genetic information in order to produce proteins. The mRNA encoding instructions for protein synthesis are transferred fr ... Read More
-
Digital Twins Market, 2022-2035
Digital Twins Market, 2022-2035 The research and development behind a new drug is reported to require, on an average, an investment of nearly USD 1 billion. At present, over 90% of the drug candidates fail across different stages of clinical trials, leading to significant financial losses for develo ... Read More
-
AI-based Drug Discovery Market (2nd Edition), 2022-2035
The discovery and development process of a novel therapeutic candidate is often tedious and fraught with several challenges. The key concern associated with the overall process is the high attrition rate, which is often attributed to the trial-and-error approach followed for the drug discovery proce ... Read More
-
Biosensors Market: Focus on Drug Discovery and Development, 2022-2035
Biosensors Market: Focus on Drug Discovery and Development, 2022-2035 The drug discovery process, which involves the identification of a relevant biological target and a corresponding pharmacological lead, is deemed crucial to the clinical success of a drug candidate. However, considering the growin ... Read More
-
Quantum Computing in Drug Discovery Services Market, 2023-2035
Quantum Computing in Drug Discovery Services Market, 2023-2035 INTRODUCTION The early stages of research related to drug discovery, including the identification of a relevant biological target and a viable lead compound, play an important role in the overall success of a drug candidate in preclinica ... Read More
-
Alzheimer’s Disease Market: Distribution by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030
Alzheimer’s Disease Market: Distribution by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030 Alzheimer’s disease is a progressive neurological disorde ... Read More
-
Peptide Therapeutics: Contract API Manufacturing Market (2nd Edition), 2022-2035 Distribution by [A] Scale of Operation (Preclinical / Clinical and Commercial) [B] Type of Synthesis Method Used [C] Company Size (Small, Mid-sized and Large), and [D] Key Geographical Regions (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts
Peptide Therapeutics: Contract API Manufacturing Market (2nd Edition), 2022-2035 Distribution by [A] Scale of Operation (Preclinical / Clinical and Commercial) [B] Type of Synthesis Method Used [C] Company Size (Small, Mid-sized and Large), and [D] Key Geographical Regions (North America, Europe, As ... Read More
-
Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035
Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035 REPORT DETAILS Product Title: Deep Learning in Drug Discovery Market and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035: Distribution by Therapeutic Area (Oncological Disorders, Infectious ... Read More
-
Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics (2nd Edition), 2021-2030: Distribution by Type of Protein degrader (degronimids, PROTACs, SARDs / SERDs, and specific BET and DUB inhibitors and other inhibitors), Therapeutic Area (Neurological Disorders, Oncological Disorders, and Other Therapeutic Areas), Route of administration (Oral, Intravenous and Others), Key Contributing Technologies and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World)
Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics (2nd Edition), 2021-2030: Distribution by Type of Protein degrader (degronimids, PROTACs, SARDs / SERDs, and specific BET and DUB inhibitors and other inhibitors), Therapeutic Area (Neurological Disorders, Oncologica ... Read More
-
DNA Synthesis Technologies and Services Market, 2022-2035
DNA Synthesis Technologies and Services Market, 2022-2035 DNA or RNA molecules find a variety of applications in the biopharmaceutical industry for genetic testing, medical research, therapeutic development, forensic investigation, and other analytical processes. It is worth highlighting that severa ... Read More
-
Live Biotherapeutic Products and Microbiome Manufacturing Market (2nd Edition), 2022-2035
Live Biotherapeutic Products and Microbiome Manufacturing Market (2nd Edition), 2022-2035 Given the advancement of several promising microbiome-based live biotherapeutic products through clinical pipeline, this upcoming therapeutic segment is anticipated to become one of the fastest growing markets ... Read More
-
Intranasal Therapeutics and Drug Delivery Systems Market, 2022-2035
Intranasal Therapeutics and Drug Delivery Systems Market, 2022-2035 Over the past few years, the prevalence of neurological disorders has increased at an annualized rate of 10.9%. Further, the mortality associated with such diseases is projected to account for 12.2% of the global death rate, in 203 ... Read More
-
Site Management Organizations Market, 2021-2035
Site Management Organizations Market, 2021-2035 INTRODUCTION Clinical trials form an integral part of the overall drug development process, enabling the necessary evaluation of the safety and efficacy of a drug candidate. Studies suggest that around 40% of the total investment made for the developme ... Read More
-
Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030
Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030 With close to 100 approved monoclonal antibodies, and over 550 molecules in the clinical pipeline, antibody based pharmacological interventions have become one of the fast gro ... Read More
-
Oral Proteins and Peptides Market (4th Edition) by Target Disease Indication (acromegaly, celiac disease, chronic idiopathic constipation, enteric hyperoxaluria, inflammatory bowel disease and type II diabetes), Type of Molecule (protein and peptide), Technology Platforms, Biological Target (GC-C, insulin receptor, oxalate and others), Mechanism of Action (receptor stimulation, substrate degradation and others) Key Players and Key Geographical Regions (North America, Europe, Asia-Pacific and RoW), 2022-2032
Oral Proteins and Peptides Market (4th Edition) by Target Disease Indication (acromegaly, celiac disease, chronic idiopathic constipation, enteric hyperoxaluria, inflammatory bowel disease and type II diabetes), Type of Molecule (protein and peptide), Technology Platforms, Biological Target (GC-C, i ... Read More
-
Site Management Organizations Market by Therapeutic Areas (Oncological Disorders, CNS Disorders, Infectious Diseases, Cardiovascular Diseases and Others), Trial Phase (Phase I, Phase II, Phase III and Phase IV), Clinical Trial Components (Site Management, Onsite Monitoring, Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035
Site Management Organizations Market by Therapeutic Areas (Oncological Disorders, CNS Disorders, Infectious Diseases, Cardiovascular Diseases and Others), Trial Phase (Phase I, Phase II, Phase III and Phase IV), Clinical Trial Components (Site Management, Onsite Monitoring, Project Management and Ot ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Sy ... Read More
-
Investor Series: Opportunities in RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers)
Investor Series: Opportunities in RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers) INTRODUCTION to RNA Therapeutics RNA therapeutics are known to target specific genetic sequences of individual patients, in order to provide more effective treatment option ... Read More
Research Assistance
